LifeScience

Biosynth Carbosynth Expands Life Sciences Platform with Acquisition of Aalto Bio Reagents

The acquisition represents a further milestone in Biosynth’s development, which broadens its capabilities and offering to the IVD industry. Aalto&rsq...

 May 30, 2022 | News

GenScript Biotech Collaborates with Singapore Institute of Technology on Talent Development and Applied Research Projects

Under the agreement, GenScript will provide internship, full-time employment, industry networking and field service project opportunities for SIT students ...

 May 26, 2022 | News

Merck Invests More Than €440 Million and Expands its Membrane and Filtration Manufacturing in Ireland

Company to invest in two major Life Science projects over five years Significantly increases membrane manufacturing capacities and enables construction ...

 May 23, 2022 | News

Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities in clinical drug development

Synexa Life Sciences BV, a global leader in specialist biomarker and bioanalysis research services, has today announced that it...

 May 20, 2022 | News

GenScript Launches GMP Single-Strand and Double-Strand DNA Service for Supporting Gene and Cell Therapy Development

 GenScript USA Inc., the world's leading life-science research tools and services provider, announced the availability of new GMP-grade ...

 May 17, 2022 | News

GenScript ProBio Establishes Korean Legal Entity and Further Strengthens Cooperation in South Korea and APAC Region

During the BIO KOREA 2022, Dr. Brian H. Min, CEO of GenScript ProBio, introduced the development history of GenScript ProBio to the participants and o...

 May 13, 2022 | News

Merck aims to significantly reduce its greenhouse gas emissions by 2030

Merck, a leading science and technology company, aims to significantly reduce its greenhouse gas emissions by 2030. The independent Science Based Targ...

 May 10, 2022 | News

SCG Cell Therapy announces HSA clinical trial approval of TCR-T cell therapy for liver cancer

SCG101 is the first TCR-T cell therapy product to receive a multi-regional Investigational New Drug (IND) approval from Singapore's Health Scie...

 May 09, 2022 | News

Merck’s First-Asia Pacific Mobius® Single-Use Manufacturing Center in Wuxi, China

Investment Supports Biotech Innovation in China Partnership with Administrative Management Committee of Wuxi National High-Tech Industrial Development Z...

 May 06, 2022 | News

Matica Bio Opens New Cell and Gene Therapy GMP Facility in Texas

Cell and Gene Therapy Specialty Building on years of cell and gene therapy expertise, Matica Bio’s new facility is now expanding its capacity as a C...

 May 04, 2022 | News

Biocytogen Enters into Antibody Agreement with Merck

Under the agreement, Biocytogen will provide Merck antibodies directed against at least three targets specified by them from Biocytogen's Project Integrum&...

 May 02, 2022 | News

Seegene unveils world's first commercialized '3 Ct' PCR assay

"Dream MDx technology" developed based on Seegene's 20-year expertise; combines 19 different patented technologies, including DPO™, TOCE™, Mu...

 April 27, 2022 | News

Thermo Fisher opens bioprocessing manufacturing facility in Ogden, UT

Thermo Fisher Scientific today celebrated the opening of its new single-use technology manufacturing site in Ogden, Utah. The state-of-the-art facility cre...

 April 21, 2022 | News

MGI announces partnership with Nalagenetics to advance personalized medicine

MGI, a company committed to being a world-leading life science innovator, today announced a partnership with Nalagenetics (NALA) to co-develop lo...

 April 19, 2022 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close